Our first 18 reports from CROI, ARV news, a review of “When to Start Treatment?”, new US guidelines and publication reviews…
Two of the most widely used treatment guides have been updated. Read online or order print copies…
The first issue of 2013 covers women’s health, global access, paediatric TB, smoking, bone health and more besides…
Two i-Base guides updated and reprinted for 2013: the Guide to Changing Treatment and the Guide to HIV Testing and Sexual Transmission. Order print copies online.
HIV Bilten is an HIV treatment and research information resource for the West Balkans, produced by Q Club, the Serbian association of people living with HIV.
These pages outline a recent course that i-Base ran for Positively UK. The numbered buttons at the bottom of the page link to each of the five sessions. Session 1: Introduction to HIV treatment and setting course priorities Topics discussed: …
News from the Glasgow Conference and the US Liver Meeting (AASLD), plus more on dolutegravir, Quad, and the importance of moving globally from use of d4T.
Este suplemento es una revisión no técnica de la conferencia de la IAS celebrada en Washington DC.
Traducción al español realizada por el gTt, Barcelona.
Stay on target with i-Base treatment guides
New translations by HIV positive organisation in Bulgarian (aidsbg.info) of the i-Base guide to Side Effects and the Introduction to Combination Therapy.
News from ICAAC, further reports from IAS 2012, new BHIVA standards and Quad approval in the US.
Interested in learning more about HIV resistance in non-technical language? Want to learn online at your own pace but still be able to ask questions? i-Base have developed a weekly on-line advocacy training about HIV drug resistance, why it happens, …
New community produced resource published in Bosnian, Montenegrin, Croatian and Serbian for Bosnia & Herzegovina, Croatia, Montenegro and Serbia.
Easy to read review from the AIDS 2012 conference held in Washington in July.
12 areas of care drafted as a model for future treatment and care services: feedback open to 12 October
Promising new drug overshadowed if price tag is significantly higher than Atripla.
Over 20 reports from Washington, Gaul stones in France, transmission of 5-drug resistance, new drugs, webcasts, activism, PrEP, bone health and other news…
As part of our IAS coverage we include links to selected webcasts.
The IAS conference was used to launch several publications that each cover important aspects of HIV treatment or access.
This annual review from i-Base/TAG covers research into upcoming drugs and diagnostic in development.